Effects of lipid-lowering therapies on lipoprotein(a) levels in patients with dyslipidemia: a systematic review and network meta-analysis of 64 randomised controlled trials
Event:
ESC Congress 2024
Topic:
Drug therapy
Session:
Lp(a): the new risk factor
